{"doi":"10.1016/j.jval.2014.03.1539","title":"A Regulatory Compararison Of Non-Insulin Dependent Type Ii Diabetes Drug Approvals In The United States And European Union","abstract":null,"journal":"Value in Health","year":2014,"id":591486,"datarank":0.10397207708399181,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.0,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":1,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1513361,"name":"J. Rubinstein","orcid":null,"position":1,"is_corresponding":false},{"id":1513362,"name":"E. Rubinstein","orcid":null,"position":2,"is_corresponding":false},{"id":1513363,"name":"R. Sliman","orcid":null,"position":3,"is_corresponding":false},{"id":1353683,"name":"K. Daniel","orcid":null,"position":4,"is_corresponding":false},{"id":1513364,"name":"Y.S. Ho","orcid":null,"position":5,"is_corresponding":false},{"id":1513360,"name":"D.P. Sanchez","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"A Regulatory Compararison Of Non-Insulin Dependent Type Ii Diabetes Drug Approvals In The United States And European Union","abstract":null,"is_dataset_classified":null,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"26657633","pmcid":null,"openalex_id":"https://openalex.org/W2321565583","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.20854291,"influential_citations":0,"citation_trend":[{"year":2026,"count":1}],"oa_status":"bronze","license":"https://www.elsevier.com/open-access/userlicense/1.0/","oa_locations":[{"url":"http://www.valueinhealthjournal.com/article/S1098301514015903/pdf","host_type":"journal"},{"url":"http://www.valueinhealthjournal.com/article/S1098301514015903/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1098301514015903?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1098301514015903?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.jval.2014.03.1539","host_type":"journal"}],"fields_of_study":["Pharmaceutical Economics and Policy","Health Systems, Economic Evaluations, Quality of Life","Pharmaceutical industry and healthcare"],"mesh_terms":[],"keywords":["Marketing authorization","Authorization","Drug approval","European commission","Regulatory science","Medicine","European union","Regulatory authority","Scope (computer science)","Commission","Pharmacology","Drug","Business","Political science","Public administration","Law","Bioinformatics","Computer science","International trade","Computer security"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-25T16:58:10.186625Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}